Hemispherx Biopharma makes headway in advancing flagship cancer drug Ampligen in 2018 - Proactive Investors USA & Canada https://t.co/0YX7tsEdHb
— IDRO (@IDROOhio) April 2, 2019
from Twitter https://twitter.com/IDROOhio
April 02, 2019 at 04:36AM
Tuesday, April 2, 2019
Hemispherx Biopharma makes headway in advancing flagship cancer drug Ampligen in 2018 - Proactive Investors USA & Canada https://t.co/0YX7tsEdHb
from Twitter https://twitter.com/IDROOhio
April 02, 2019 at 04:36AM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment